It’s time to buy Isis Pharmaceuticals (ISIS)
Dec 19th, 2008 | By Laura Cadden | Category: Financial NewsIsis Pharmaceuticals, Inc. (NASDAQ:ISIS) is a biopharmaceutical company that focuses entirely on RNA-based technologies and primarily, on antisense therapies.
